[1] [7] Additionally, because glucagon promotes glycogenolysis and gluconeogenesis, there is a theoretical concern regarding glucose management in people with type 2 diabetes, although the GLP-1 and GIP components appear to counterbalance this effect in practice
By mimicking GLP-1, semaglutide stimulates the production of insulin, lowers blood glucose levels and triggers signals of fullness in the brain, reducing appetite
The Fueled Framework system is designed to help GLP-1 users build exactly this kind of structure so that every meal supports the outcome the medication is working toward
If you are taking any medication, or have any type of medical issue, consult with a doctor before using this product
For example, instead of starting with the manufacturers recommended start dose for weight-loss or diabetes, a person might take a fraction of that dose